Olympus Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Olympus in the last year. There are currently 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" Olympus stock.
View analyst ratings for Olympus or view top-rated stocks.

Wall Street analysts have given Olympus a "Strong Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Olympus wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Olympus saw a increase in short interest in the month of January. As of January 29th, there was short interest totaling 9,200 shares, an increase of 100.0% from the January 14th total of 4,600 shares. Based on an average daily volume of 47,400 shares, the days-to-cover ratio is currently 0.2 days.
View Olympus' Short Interest.

Olympus is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for Olympus.

Olympus Co. (OTCMKTS:OCPNY) issued its earnings results on Wednesday, August, 5th. The company reported ($0.02) earnings per share for the quarter, topping analysts' consensus estimates of ($0.03) by $0.01. The business earned $1.32 billion during the quarter, compared to the consensus estimate of $1.29 billion. Olympus had a trailing twelve-month return on equity of 10.82% and a net margin of 5.34%.
View Olympus' earnings history.

Olympus' stock was trading at $17.6660 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, OCPNY shares have increased by 22.4% and is now trading at $21.62.
View which stocks have been most impacted by COVID-19.

Olympus pays an annual dividend of $0.07 per share and currently has a dividend yield of 0.33%. The dividend payout ratio of Olympus is 19.44%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Olympus will have a dividend payout ratio of 11.48% next year. This indicates that Olympus will be able to sustain or increase its dividend.
View Olympus' dividend history.

Some companies that are related to Olympus include Sanofi (SNY), CSL (CSLLY), Stryker (SYK), AstraZeneca PLC (AZN.L) (AZN), Intuitive Surgical (ISRG), GlaxoSmithKline (GSK), Gilead Sciences (GILD), Zoetis (ZTS), Anthem (ANTM), Becton, Dickinson and (BDX), Illumina (ILMN), Bayer Aktiengesellschaft (BAYRY), GlaxoSmithKline (GSK), HCA Healthcare (HCA) and Moderna (MRNA).
View all of OCPNY's competitors.

Olympus trades on the OTCMKTS under the ticker symbol "OCPNY."

Shares of OCPNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OCPNY stock can currently be purchased for approximately $21.62.

Olympus has a market capitalization of $29.64 billion and generates $7.32 billion in revenue each year. The company earns $475.36 million in net income (profit) each year or $0.36 on an earnings per share basis.

Olympus employs 35,174 workers across the globe.

The following companies are subsidiares of Olympus: AVS Co Ltd, Aizu Olympus Co Ltd, Algram Group Ltd, Aomori Olympus Co Ltd, Arc Medical Design Limited, Image Stream Medical Inc, Nagano Olympus Co Ltd, Olympus (Beijing) Sales & Service Co Ltd, Olympus (China) Co Ltd, Olympus (GuangZhou) Industrial Co Ltd, Olympus (Malaysia) Sdn Bhd, Olympus (Thailand) Co Ltd, Olympus America Inc, Olympus America de Mexico SA de CV, Olympus Australia Pty Ltd, Olympus Austria Gesellschaft mbH, Olympus Belgium SA/NV, Olympus Canada Inc, Olympus Corporation of Asia Pacific Limited, Olympus Corporation of the Americas, Olympus Czech Group sro, Olympus Danmark A/S, Olympus Deutschland GmbH, Olympus Digital System Design Corp, Olympus Estonia Oü, Olympus Europa SE & Co KG, Olympus Finland OY, Olympus France SAS, Olympus Hong Kong and China Limited, Olympus Iberia SAU, Olympus Ireland, Olympus Italia SRL, Olympus Korea Co Ltd, Olympus Latin America Inc, Olympus Logitex Co Ltd, Olympus MEA FZ-LLC, Olympus Medical Science Sales Corp, Olympus Medical Systems Corp, Olympus Medical Systems India Private Limited, Olympus Medical Systems Vietnam Co Ltd, Olympus Memory Works Corp, Olympus Moscow Limited Liability Company, Olympus NDT Canada Inc, Olympus Nederland BV, Olympus New Zealand Limited, Olympus Norge A/S, Olympus Optical do Brasil Ltda, Olympus Polska sp zoo, Olympus Schweiz AG, Olympus Scientific Solutions Americas Corp, Olympus Scientific Solutions Technologies Inc, Olympus Singapore Pte Ltd, Olympus Soft Imaging Solutions GmbH, Olympus Surgical Technologies America Inc, Olympus Surgical Technologies Europe (Olympus Winter & Ibe GmbH), Olympus Sverige AB, Olympus Systems Corporation, Olympus Taiwan Co Ltd, Olympus Terumo Biomaterials Corp, Olympus Trading (Shanghai) Limited, Olympus UK & Ireland, Olympus Vietnam Co Ltd, Olympus doo Beograd, Olympus-RMS Corp, Olympus-Supportmate Corp, Shirakawa Olympus Co Ltd, Sony Olympus Medical Solutions Inc, Tecnologias Opticas e Digitais Lda, and TmediX Corporation.

Olympus was founded in 1919.

The official website for Olympus is www.olympus-global.com.

Olympus is headquartered at SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, TOKYO M0, 163-0914.

Olympus' mailing address is SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, TOKYO M0, 163-0914. The company can be reached via phone at 813-3340-2111 or via email at [email protected]